Anders Hove is listed as a director on 5 SEC Form D filings by 2 issuers between Oct 2009 and Jan 2012: Mevion Medical Systems, Inc. (Littleton, MA — biotechnology — 2011–2012; $58.8M reported sold to 18 investors) and Virdante Pharmaceuticals, Inc. (Cambridge, MA — pharmaceuticals — 2009–2011; $30.1M reported sold to 10 investors).
What this means 2 separate companies raised money with this person listed as director, over about 3 years. Across those companies the filings report $88.9M sold in total.
Listed alongside Eric Aguiar (3 shared filings), Gail Wasserman (3 shared filings), John Ripple (3 shared filings), L. Patrick Gage (3 shared filings), Michael Steinmetz (3 shared filings) and 9 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Anders. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 5 public filings for Anders Hove and found 6 differences: No amendment in the last 12 months on an offering that may still be open; Same name, different state: "Anders D. Hove" (NY) is a separate record; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.